A new study shows that a pioneering initiative to prevent shaken baby syndrome was associated with a 35-per-cent reduction in the number of children under two admitted to B.C. hospitals with shaking-related injuries.
The main focus of our basic science and clinical research is in pediatric liver disease. Our basic laboratory has developed mouse models that allow us to study some of the mechanisms of injury in the bile duct (the tube that drains bile from the liver into the intestine) that result in liver diseases such as biliary atresia or primary sclerosing cholangitis.
We also use cell culture techniques to specifically examine how immune cells recognize and target the bile duct cell injury, with the hope of being able to develop new drug therapy to treat these diseases.
In our clinical research, we are the Canadian lead centre for studying all Canadian pediatric patients diagnosed with biliary atresia. Our aim is to understand the long-term outcome of this pediatric disease and to develop novel strategies to improve both the diagnosis and treatment.
Development and Validation of a Disease-Specific Health-Related Quality of Life Questionnaire for Children After Liver Transplantation
A CIHR-funded study of Canadian children post liver transplant.
Neonatal biliary atresia in Canada: Long term experience 1985-2002
Established a Canadian wide database of patients with biliary atresia.
Immune mediated bile duct epithelial injury
Using standard immune assays and murine derived in vivo systems and in vitro cell culture, our laboratory examines the mechanisms of immunocyte recognition of bile duct epithelial cells in healthy and disease states.Grants
CIHR Planning Grant - Project: "Canadian Biliary Atresia Registry Planning Meeting."Research Group Members
Crystal Ng, Research Coordinator, CAPSNet and CBAR